A Side-by-Side Analysis of EBITDA: Accenture plc and Manhattan Associates, Inc.

Accenture vs. Manhattan: A Decade of EBITDA Growth

__timestampAccenture plcManhattan Associates, Inc.
Wednesday, January 1, 20144903240000133501000
Thursday, January 1, 20155071031000169210000
Friday, January 1, 20166348882000203397000
Sunday, January 1, 20175433366000197626000
Monday, January 1, 20186754408000142500000
Tuesday, January 1, 20197167520000123911000
Wednesday, January 1, 20207986088000123007000
Friday, January 1, 20217621529000142247000
Saturday, January 1, 202210554225000159363000
Sunday, January 1, 202310587612000215633000
Monday, January 1, 202411188334000267897000
Loading chart...

In pursuit of knowledge

A Comparative Analysis of EBITDA Growth: Accenture vs. Manhattan Associates

In the ever-evolving landscape of global business, understanding the financial health of industry leaders is crucial. This analysis delves into the EBITDA performance of Accenture plc and Manhattan Associates, Inc. from 2014 to 2024. Over this decade, Accenture has demonstrated a robust growth trajectory, with its EBITDA increasing by approximately 128%, from $4.9 billion in 2014 to an impressive $11.2 billion in 2024. In contrast, Manhattan Associates, while smaller in scale, has shown a steady rise of around 105%, growing from $133 million to $273 million over the same period. This side-by-side comparison highlights Accenture's dominant market position, yet underscores Manhattan's consistent growth in a competitive environment. As businesses navigate the complexities of the modern economy, these insights provide valuable perspectives on strategic financial management.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
28 Jan 2025